The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Open accessAbstract
As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mucocutaneous and visceral disease can be lethal if untreated, but most deaths are attributable to visceral leishmaniasis (103).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depending on the species, Leishmania can cause self-healing cutaneous lesions (e.g., L. tropica, L. major, L. mexicana, and L. pifanoi), disfiguring mucocutaneous disease (e.g., L. braziliensis and L. guyanensis), or severe visceral illness (e.g., L. donovani and L. Infantum chagasi).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredIn the citing paper
“we must consider the important zoonotic potential of the diseases studied, as the presence of human infections or risk of infection has already been described (5, 24, 25, 28).”
From Current Distribution of Selected Vector-Borne Diseases in Dogs in Spain (2020) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
BackgroundBank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
BackgroundHealth metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
BackgroundAlvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
BackgroundDesjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
BackgroundLibrary, W. (2010) · Cited by 584
Flagged first, then by citations
Research works printed but not linked: 1
- AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931
Cited by
Sorted by citations
Items 801–900 of 1,004
Hlavačková, K., Dvořák, V., Chaskopoulou, A., Volf, P., & Halada, P. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007669 · Cited by 42
Wild mammals as potential silent reservoirs of Leishmania infantum in a Mediterranean area
Alcover, M. M., Ribas, A., Guillén, M. C., Berenguer, D., Tomás-Pérez, M., Riera, C., & Fisa, R. (2019) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2019.104874 · Cited by 42
Filgueira, C. P. B., Moreira, O. C., Cantanhêde, L. M., de Farias, H. M. T., Porrozzi, R., Britto, C., Boité, M. C., & Cupolillo, E. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008750 · Cited by 42
Insights into the Antimicrobial Potential of Dithiocarbamate Anions and Metal-Based Species
Yeo, C. I., Tiekink, E. R. T., & Chew, J. (2021) · Inorganics · doi:10.3390/inorganics9060048 · Cited by 42
Cruz‐Saavedra, L., Díaz-Roa, A., Gaona, M. A., Cruz, M. L., Ayala, M. S., Cortés‐Vecino, J. A., Patarroyo, M. A., & Bello, F. J. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.09.020 · Cited by 41
Alharazi, T. H., Haouas, N., & Al‐Mekhlafi, H. M. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05965-4 · Cited by 41
Benallal, K. E., Garni, R., Harrat, Z., Volf, P., & Dvořák, V. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009952 · Cited by 41
Özbel, Y., Töz, S. O., Muñoz-Hernández, C., Ortuño, M., Jumakanova, Z., Pérez‐Cutillas, P., Maia, C., Conceição, C., Baneth, G., Pereira, A. B., et al. (2022) · Zoonoses and Public Health · doi:10.1111/zph.12977 · Cited by 41
“The incidence of human leishmaniasis between 2004 and 2008 has been previously analysed (Alvar et al., 2012).”
BackgroundInfluentialFitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major
Turner, K. G., Vacchina, P., Robles‐Murguia, M., Wadsworth, M. N., McDowell, M. A., & Morales, M. A. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003948 · Cited by 41
de Macedo-Silva, S. T., Visbal, G., Urbina, J. A., de Souza, W., & Rodrigues, J. C. F. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01150-15 · Cited by 41
Polymorphism in the HASPB Repeat Region of East African Leishmania donovani Strains
Zackay, A., Nasereddin, A., Takele, Y., Tadesse, D., Hailu, W., Hurissa, Z., Yifru, S., Weldegebreal, T., Diro, E., Kassahun, A., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002031 · Cited by 41
da Silva, M. A. L., de Medeiros, Z. M., Soares, C. R. P., da Silva, E. D., Miranda-Filho, D. B., & de Melo, F. L. (2014) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0233-2013 · Cited by 41
Godinho, J. L. P., Georgikopoulou, K., Calogeropoulou, T., de Souza, W., & Rodrigues, J. C. F. (2013) · Experimental Parasitology · doi:10.1016/j.exppara.2013.06.015 · Cited by 41
Cuervo-Escobar, S., Losada-Barragán, M., Umaña‐Pérez, A., Porrozzi, R., Vahia, L. S., de Miranda, L. H. M., Morgado, F. N., Menezes, R. C., Sánchez-Gómez, M., & Cuervo, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114584 · Cited by 41
Fonseca, A. M., Faria, A. R., Rodrigues, F. T. G., Nagem, R. A. P., Magalhães, R. D. M., Reis-Cunha, J. L., Bartholomeu, D. C., & de Andrade, H. M. (2014) · Acta Tropica · doi:10.1016/j.actatropica.2014.04.028 · Cited by 41
Therapeutic Potential of Biogenic Silver Nanoparticles in Murine Cutaneous Leishmaniasis
Rossi‐Bergmann, B., Lima, W. P., Marcato, P. D., Conti, R. D., & Durán, N. (2012) · Journal of nano research · doi:10.4028/www.scientific.net/jnanor.20.89 · Cited by 41
Epidemiological study on acute cutaneous leishmaniasis in Morocco
Kahime, K., Boussaa, S., Idrissi, A. L. E., Nhammi, H., & Boumezzough, A. (2015) · Journal of Acute Disease · doi:10.1016/j.joad.2015.08.004 · Cited by 41
PD-1 function in apoptosis of T lymphocytes in canine visceral leishmaniasis
Chiku, V. M., Silva, K. L. O., de Almeida, B. F. M., Venturin, G. L., Leal, A. A. C., de Martini, C. C., Eugênio, F. D. R., dos Santos, P. S. P., & de Lima, V. M. F. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.03.007 · Cited by 41
Patiño, L. H., & Ramírez, J. D. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.02.003 · Cited by 41
Leitherer, S., Clos, J., Liebler–Tenorio, E., Schleicher, U., Bogdan, C., & Soulat, D. (2017) · Infection and Immunity · doi:10.1128/iai.00084-17 · Cited by 41
Urbanization of human visceral leishmaniasis in Morocco
Kahime, K., Boussaa, S., Nhammi, H., & Boumezzough, A. (2017) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2017.07.001 · Cited by 41
A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
Duthie, M. S., Pereira, L. D. S., Favila, M. A., Hofmeyer, K. A., Reed, J., Metangmo, S., Townsend, S. E., Laurance, J. D., Picone, A., Misquith, A., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0025-5 · Cited by 41
Gholami, E., Oliveira, F., Taheri, T., Seyed, N., Gharibzadeh, S., Gholami, N., Mizbani, A., Zali, F., Habibzadeh, S., Bakhadj, D. O., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007067 · Cited by 41
Target Product Profile for a point-of-care diagnostic test for dermal leishmaniases
Cruz, I., Albertini, A., Barbeitas, M. M., Arana, B. A., Picado, A., Ruiz-Postigo, J. A., & Ndung’u, J. M. (2019) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2019.e00103 · Cited by 41
Fernandes, J. C. R., Aoki, J. I., Maia Acuña, S., Zampieri, R. A., Markus, R. P., Floeter-Winter, L. M., & Muxel, S. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00060 · Cited by 41
Ovalle‐Bracho, C., Londoño-Barbosa, D., Salgado‐Almario, J., & González, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214124 · Cited by 41
Emerging and threatening vector-borne zoonoses in the world and in Europe: a brief update
Jánová, E. (2019) · Pathogens and Global Health · doi:10.1080/20477724.2019.1598127 · Cited by 47
Koeppen, D., Aurich, M., Pasalar, M., & Rampp, T. (2019) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2019.08.003 · Cited by 41
The Delay in the Licensing of Protozoal Vaccines: A Comparative History
Palatnik, M., & Nico, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00204 · Cited by 41
Remadi, L., Chargui, N., Jiménez, M., Molina, R., Haouas, N., González, E., Chaâbane-Banaoues, R., Salah, E. B., Haddaji, M., Chaabouni, Y., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008077 · Cited by 41
Minori, K., Rosa, L. B., Bonsignore, R., Casini, A., & Miguel, D. C. (2020) · ChemMedChem · doi:10.1002/cmdc.202000536 · Cited by 41
Mohammadi, M., Zaki, L., KarimiPourSaryazdi, A., Tavakoli, P., Tavajjohi, A., Poursalehi, R., Hamid Delavari, H., & Ghaffarifar, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255571 · Cited by 41
Paternina, L. E., Verbel‐Vergara, D., Romero-Ricardo, L., Pérez-Doria, A., Gómez, M. P., Abad, L. P. M., & Bejarano, E. E. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.10.005 · Cited by 41
Maretti-Mira, A. C., Bittner, J., Oliveira-Neto, M. P., Liu, M., Kang, D., Li, H., Pirmez, C., & Craft, N. A. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001816 · Cited by 41
Epidemiology of Visceral Leishmaniasis in Georgia
Babuadze, G. G., Alvar, J., Argaw, D., de Koning, H. P., Iosava, M., Kekelidze, M., Tsertsvadze, N. S., Tsereteli, D., Chakhunashvili, G., Mamatsashvili, T., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002725 · Cited by 41
Want, M. Y., Islamuddin, M., Chouhan, G., Dasgupta, A. K., Chattopadhyay, A. P., & Afrin, F. (2014) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.06.035 · Cited by 41
Chaves, L. F., Calzada, J. E., Rigg, C., Valderrama, A., Gottdenker, N. L., & Saldaña, A. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-164 · Cited by 41
Mathematical analysis of a model for AVL–HIV co-endemicity
Hussaini, N., Lubuma, J. M.-S., Barley, K., & Gumel, A. B. (2015) · Mathematical Biosciences · doi:10.1016/j.mbs.2015.10.008 · Cited by 40
Andrade, M. S., Courtenay, O., de Brito, M. E. F., de Carvalho, F. G., de Carvalho, A. W. S., Soares, F. C. S., Carvalho, S. M. S., Costa, P. L., Zampieri, R. A., Floeter‐Winter, L. M., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004137 · Cited by 42
Mukhtar, M. M., Abdoun, A., Ahmed, A. E., Ghalib, H., Reed, S. G., Boelaert, M., Menten, J., Kheir, M. M., & Howard, R. F. (2015) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trv060 · Cited by 40
(Post-) Genomic approaches to tackle drug resistance in Leishmania
Berg, M., Mannaert, A., Vanaerschot, M., der Auwera, G. V., & Dujardin, J. (2013) · Parasitology · doi:10.1017/s0031182013000140 · Cited by 40
Stauch, A., Duerr, H.-P., Picado, A., Ostyn, B., Sundar, S., Rijal, S., Boelaert, M., Dujardin, J., & Eichner, M. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002810 · Cited by 40
Magalhães‐Junior, J. T., Mesquita, P. R. R., Oliveira, W. F. D. S., de Oliveira, F. S., Franke, C. R., Rodrigues, F. D. M., de Andrade, J. B., & Barrouin‐Melo, S. M. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8103-2 · Cited by 40
Oliveira, M. B., Calixto, G. M. F., Graminha, M. A. S., Cerecetto, H., González, M., & Chorilli, M. (2015) · BioMed Research International · doi:10.1155/2015/396894 · Cited by 40
Beattie, L., Hermida, M. D.-R., Moore, J. W. J., Maroof, A., Brown, N., Lagos, D., & Kaye, P. M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.08.004 · Cited by 40
Samy, A. M., Campbell, L. P., & Peterson, A. T. (2014) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0189-2013 · Cited by 40
Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
Rodríguez‐Hernández, D., Barbosa, L. C. A., Demuner, A. J., de Almeida, R. M., Fujiwara, R. T., & Ferreira, S. R. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.030 · Cited by 40
Exploring Spatial and Temporal Distribution of Cutaneous Leishmaniasis in the Americas, 2001–2011
Maia‐Elkhoury, A. N. S., Yadón, Z. E., Saboyá-Díaz, M. I., Lucena, F. D. F., Castellanos, L. G., & Sanchez-Vazquez, M. J. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005086 · Cited by 41
Marine Algae as Source of Novel Antileishmanial Drugs: A Review
Tchokouaha, L. R. Y., Appiah‐Opong, R., Fokou, P. V. T., Tsabang, N., Boyom, F. F., Nyarko, A. K., & Wilson, M. D. (2017) · Marine Drugs · doi:10.3390/md15110323 · Cited by 40
Karimian, F., Vatandoost, H., Rassi, Y., Maleki‐Ravasan, N., Choubdar, N., Koosha, M., Arzamani, K., Asl, E. M., Veysi, A., Alipour, H., et al. (2018) · Pathogens and Global Health · doi:10.1080/20477724.2018.1471438 · Cited by 40
Genomic insights into virulence mechanisms of Leishmania donovani: evidence from an atypical strain
Samarasinghe, S. R., Samaranayake, N., Kariyawasam, U., Siriwardana, Y. D., Imamura, H., & Karunaweera, N. D. (2018) · BMC Genomics · doi:10.1186/s12864-018-5271-z · Cited by 40
Interventions to treat cutaneous leishmaniasis in children: A systematic review
Uribe-Restrepo, A. F., Cossio, A., Desai, M. M., Davalos, D. M., & Castro, M. D. M. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006986 · Cited by 40
Esfandiari, F., Motazedian, M. H., Asgari, Q., Morowvat, M. H., Molaei, M., & Heli, H. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.105045 · Cited by 40
Karimian, F., Vatandoost, H., Rassi, Y., Maleki‐Ravasan, N., Mohebali, M., Shirazi, M. H., Koosha, M., Choubdar, N., & Oshaghi, M. A. (2019) · Parasites & Vectors · doi:10.1186/s13071-018-3273-y · Cited by 40
Muxel, S. M., Mamani‐Huanca, M., Aoki, J. I., Zampieri, R. A., Floeter‐Winter, L. M., López‐Gonzálvez, Á., & Barbas, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246248 · Cited by 39
Leishmanicidal activity of Piper marginatum Jacq. from Santarém-PA against Leishmania amazonensis
Macêdo, C. G., Fonseca, M. Y. N., Caldeira, A. D., de Castro, S. P., Lima, W. P., Borsodi, M. P. G., Sartoratto, A., Silva, M., Salgado, C. G., Rossi‐Bergmann, B., et al. (2020) · Experimental Parasitology · doi:10.1016/j.exppara.2020.107847 · Cited by 40
Berenguer, D., Alcover, M. M., Sessa, M., Halbaut, L., Guillen, C., Boix‐Montañés, A., Fisa, R., Calpena, A. C., Riera, C., & Sosa, L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020149 · Cited by 40
Tulchinsky, T. H., & Varavikova, E. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-415766-8.00004-5 · Cited by 40
Mesa, L. E., Vasquez, D., Lutgen, P., Vélez, I. D., Restrepo, A. M., Ortiz, I., & Robledo, S. M. (2017) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0457-2016 · Cited by 39
Valero, N. N. H., Prist, P. R., & Uriarte, M. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.148960 · Cited by 39
Amini, S. M., Hadighi, R., Najm, M., Alipour, M., Hasanpour, H., Vosoogh, M., Vosough, A., Hajizadeh, M., & Badirzadeh, A. (2023) · Current Microbiology · doi:10.1007/s00284-022-03172-1 · Cited by 39
Moncaz, A., Kirstein, O. D., Gebreselassie, A., Lemma, W., Yared, S., Gebre-Michael, T., Hailu, A., Shenker, M., & Warburg, A. (2014) · Acta Tropica · doi:10.1016/j.actatropica.2014.06.013 · Cited by 39
Hajjaran, H., Mohebali, M., Teimouri, A., Oshaghi, M. A., Mirjalali, H., Kazemirad, E., Shiee, M. R., & Naddaf, S. R. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.05.026 · Cited by 39
Grimaldi, G., Têva, A., Porrozzi, R., Pinto, M. A., Marchevsky, R. S., Rocha, M. G. L., Dutra, M. S., Bruña–Romero, O., Fernandes, A.-P., & Gazzinelli, R. T. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002853 · Cited by 39
Vlková, M., Šíma, M., Rohoušová, I., Košťálová, T., Sumová, P., Volfová, V., Jaske, E. L., Barbian, K., Gebre-Michael, T., Hailu, A., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002709 · Cited by 39
Sharifi, I., Ghatee, M. A., Haghdoost, A. A., Kanannejad, Z., Taabody, Z., Hatam, G., & Abdollahipanah, A. (2013) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.120921 · Cited by 39
Gebresilassie, A., Abbasi, I., Aklilu, E., Yared, S., Kirstein, O. D., Moncaz, A., Tekie, H., Balkew, M., Warburg, A., Hailu, A., et al. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0883-5 · Cited by 39
de Almeida, P. S., Sciamarelli, A., Batista, P. M., Ferreira, A. D., do Nascimento, J. A., Raizer, J., Filho, J. D. A., & Gurgel‐Gonçalves, R. (2013) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276130331 · Cited by 39
Oré, M., Sáenz, E., Cabrera, R., Sanchez, J. F., Santos, M. B. D. L., Lucas, C. M., Núñez, J. H., Edgel, K. A., Sopan, J., Fernández, J. O., et al. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0107 · Cited by 39
Yamada, K., Valderrama, A., Gottdenker, N. L., Cerezo, L., Minakawa, N., Saldaña, A., Calzada, J. E., & Chaves, L. F. (2016) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2016.03.003 · Cited by 39
Denlinger, D. S., Creswell, J. A., Anderson, J. L., Reese, C. K., & Bernhardt, S. A. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1496-3 · Cited by 39
Petitdidier, E., Pagniez, J., Papierok, G., Vincendeau, P., Lemesre, J.-L., & Bras‐Gonçalves, R. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004614 · Cited by 39
da Silva, K. R., Fundação Oswaldo Cruz-Fiocruz, B., de Mendonça, V. R. R., Silva, K. M., do Nascimento, L. F. M., Mendes‐Sousa, A. F., de Pinho, F. A., Barral‐Netto, M., Barral, A. M. P., Cruz, M. D. S. P. E., et al. (2017) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760160305 · Cited by 39
Alzahrani, K. J., Ali, J. A. M., Eze, A. A., Looi, W. L., Tagoe, D. N. A., Creek, D. J., Barrett, M. P., & de Koning, H. P. (2017) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2017.04.003 · Cited by 39
Abongomera, C., Diro, E., Vogt, F., Tsoumanis, A., Mekonnen, Z., Admassu, H., Colebunders, R., Mohammed, R., Ritmeijer, K., & van Griensven, J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix607 · Cited by 39
Mendonça, D. V. C., Martins, V. T., Lage, D. P., Dias, D. S., Ribeiro, P. A. F., Carvalho, A. M. R. S., Dias, A. L. T., Miyazaki, C. K., Menezes‐Souza, D., Roatt, B. M., et al. (2018) · Experimental Parasitology · doi:10.1016/j.exppara.2018.02.003 · Cited by 39
Comparative genomics of Leishmania (Mundinia)
Butenko, A., Kostygov, A. Y., Sádlová, J., Kleschenko, Y., Bečvář, T., Podešvová, L., Macedo, D. H., Žihala, D., Lukeš, J., Bates, P. A., et al. (2019) · BMC Genomics · doi:10.1186/s12864-019-6126-y · Cited by 39
Leishmania infantum in wild animals in endemic areas of southern Italy
Abbate, J. M., Arfuso, F., Napoli, E., Gaglio, G., Giannetto, S., Latrofa, M. S., Otranto, D., & Brianti, E. (2019) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2019.101374 · Cited by 39
Alexandre, J., Sádlová, J., Leštinová, T., Vojtková, B., Jančářová, M., Podešvová, L., Yurchenko, V., Dantas‐Torres, F., Brandão-Filho, S. P., & Volf, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-60600-7 · Cited by 39
Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination
Singh, O. P., Hasker, E. C., Boelaert, M., Sacks, D. L., & Sundar, S. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008363 · Cited by 39
Overcoming roadblocks in the development of vaccines for leishmaniasis
Kaye, P. M., Mohan, S., Mantel, C. F., Malhame, M., Revill, P. A., Rutte, E. A. L., Parkash, V., Layton, A., Lacey, C. J., & Malvolti, S. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1990043 · Cited by 39
Immunity to Visceral Leishmaniasis: Implications for Immunotherapy
Khadem, F., & Uzonna, J. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.43 · Cited by 39
Gebresilassie, A., Kirstein, O. D., Yared, S., Aklilu, E., Moncaz, A., Tekie, H., Balkew, M., Warburg, A., Hailu, A., & Gebre-Michael, T. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0849-7 · Cited by 39
Jamal, S., & Scaria, V. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-329 · Cited by 39
Sádlová, J., Šeblová, V., Votýpka, J., Warburg, A., & Volf, P. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0765-x · Cited by 39
Veras, P. S. T., & de Menezes, J. B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081270 · Cited by 39
Dalvi, A. P. R., de Carvalho, T. D. G., & Werneck, G. L. (2018) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2017.2162 · Cited by 38
Lobomycosis in Soldiers, Colombia
Arenas, C., Rodriguez, G., Flórez, A. O., & Serrato, I. (2019) · Emerging infectious diseases · doi:10.3201/eid2504.181403 · Cited by 38
Bamorovat, M., Sharifi, I., Khosravi, A., Aflatoonian, M. R., Afshari, S. A. K., Salarkia, E., Sharifi, F., Aflatoonian, B., Gharachorloo, F., Khamesipour, A., et al. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00190-z · Cited by 38
In Vitro Susceptibility of Leishmania infantum to Artemisinin Derivatives and Selected Trioxolanes
Cortes, S., Albuquerque-Wendt, A., Cabral, L. I. L., Bento‐Lopes, L., Campino, L., & Cristiano, M. L. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00298-15 · Cited by 38
Infectious disease risk from the Syrian conflict
Petersen, E., Baekeland, S., Memish, Z. A., & Leblebicioğlu, H. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.06.001 · Cited by 38
Kato, H., Calvopiña, M., Criollo, H., & Hashiguchi, Y. (2013) · Acta Tropica · doi:10.1016/j.actatropica.2013.09.001 · Cited by 38
Júnior, A. T., Silva, R. E., do Carmo, R. F., Amaral, T. A., da Luz, Z. M. P., & Rabello, A. (2013) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trt021 · Cited by 38
Bayesian meta‐analysis of diagnostic tests allowing for imperfect reference standards
Menten, J., Boelaert, M., & Lesaffre, E. M. E. H. (2013) · Statistics in Medicine · doi:10.1002/sim.5959 · Cited by 38
Werneck, G. L., Costa, C. H. N., Carvalho, F. A. D. A., Cruz, M. D. S. P. E., Maguire, J. H., & Castro, M. C. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003172 · Cited by 38
Development assistance for neglected tropical diseases: progress since 2009
Liese, B. H., Houghton, N., & Teplitskaya, L. (2014) · International Health · doi:10.1093/inthealth/ihu052 · Cited by 38
Spotin, A., Rouhani, S., & Parvizi, P. (2014) · BioMed Research International · doi:10.1155/2014/913510 · Cited by 38
van den Bogaart, E., Berkhout, M. M. Z., Bym, N., Mens, P. F., Talha, A. A., Adams, E. R., Ahmed, H. B., Abdelrahman, S. H., Ritmeijer, K., Nour, B. Y. M., et al. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-332 · Cited by 38
Velásquez, L. G., Galuppo, M. K., de Rezende, E., Brandão, W. N., Peron, J. P. S., Uliana, S. R. B., Duarte, M. I. S., & Stolf, B. S. (2016) · Parasitology · doi:10.1017/s003118201600024x · Cited by 38
Protease inhibitors in potential drug development for Leishmaniasis.
Das, P., Mn, A., Paik, D., Karmakar, K., De, T., & Chakraborti, T. (2013) · PubMed · Cited by 38
Metadata
- Authors
- Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
- Affiliations
- World Health Organization (CH)
- Universidad de Antioquia (CO)
- Centers for Disease Control and Prevention (US)
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Alvar, Jorge
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-31
- Volume
- 7
- Issue
- 5
- Pages
- e35671
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3365071
- OpenAlex
- W2107915297
- Cited by
- 5,141
- References
- 51
- Citations by year
- 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
- FWCI
- 310.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Sanofi
- Universidad de Medellín
- Pan American Health Organization
- Agencia Española de Cooperación Internacional para el Desarrollo
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
- Keywords
- leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
- MeSH terms
- Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review